Lymphoma
The lymph in the human body is actually complicated. Lymphoma is the fastest and the highest death in malignant tumors, because the lymphatic system of the human body has a great effect on the whole body. Once cancer cells appear, they will spread along the blood , It will be spread all over the body, which makes the treatment more difficult. Lymphoma targeted drugs are not completely free of side effects. The patients who use them must carefully observe their changes bit by bit and communicate with the doctor in time to be able to reduce.
ຢາທີ່ຖືກເປົ້າ ໝາຍ ສຳ ລັບໂຣກ lymphoma ມີປະສິດຕິຜົນບໍ?
Early malignant lymphoma is actually lymphoma. When using targeted drugs, you must first perform genetic testing on the patient. When you find the corresponding targeted drugs, the targeted drugs have a direct killing effect on cancer cells. The advantage is that the damage to normal cells is not too great. Although there are side effects and drug resistance, it depends on the patient’s physical function, good physical fitness, high immunity, and the best therapeutic effect. Therefore, patients with lymphoma have to find ways to improve their immune function and enhance their resistance to tumors while using targeted drugs.
Targeted drug therapy affects the biological processes of cells, acting in different ways, preventing cancer cells from growing or dividing, causing cancer cells to die or using their own immune system to help the body kill cancer cells. Compared with chemotherapy, targeted drugs can act more precisely on lymphoma cells and reduce the impact of treatment on healthy cells, thereby reducing the side effects of treatment while being more effective.
ຢາທີ່ມີເປົ້າ ໝາຍ ແມ່ນຫຍັງ ສຳ ລັບໂຣກ lymphoma?
Rituximab is the first targeted immunotherapy drug used to treat lymphoma. There are many other targeted drugs for the treatment of patients with lymphoma, some have been approved for marketing, and many drugs are still in clinical trials.
1. ມະເຮັງຕ່ອມນ້ຳມູກຊຳເຮື້ອ (CLL) / ມະເຮັງລຳໄສ້ນ້ອຍ (SLL)
• Ibrutinib (Ibutinib, Imbruvica Eke)
• Idelalisib (Edelalis, Zydelig)
• Obinutuzumab (Atoruzumab, Gazyva)
• Rituximab (rituximab, Rituxan merova)
2. ຜິວ ໜັງ (ຜິວ ໜັງ) T cell lymphoma
• Brentuximab Vedotin (Bentuximab, Adcetris)
3. Diffuse lymphoma B-cell ຂະ ໜາດ ໃຫຍ່
• Rituximab (rituximab, Rituxan merova)
4. ໂຣກ lymphoma Follicular
• Idelalisib (Edelalis, Zydelig)
• Obinutuzumab (Atoruzumab, Gazyva)
• Rituximab (rituximab, Rituxan merova)
• Ibritumomab Tiuxetan (Timobizumab, Zevalin)
5. ຄລາສິກ Hodgkin lymphoma
• Brentuximab Vedotin (Bentuximab, Adcetris)
• Nivolumab (Navuliu monoclonal antibody, Opdivo).
• Pembrolizumab (Pambrolizumab, Keytruda)
6. ມະເລັງ B-cell mediastinal ຂັ້ນຕົ້ນ
• Rituximab (rituximab, Rituxan merova)
7. lymphoma cell Mantle
• Bortezomib (bortezomib, Velcade Velcade)
• Ibrutinib (Ibutinib, Imbruvica Eke)
•ສານທີ່ບໍ່ຖືກຕ້ອງ (Lenalidomide, Revlimid)
• Temsirolimus (ສຳ ລັບ sirolimus, Torisel)
8. lymphoma ຫ້ອງຂະຫນາດໃຫຍ່ anaplastic ລະບົບ
• Brentuximab Vedotin (Bentuximab, Adcetris)
ບໍ່ມີຕົວເລກມາດຕະຖານ ສຳ ລັບລາຄາຂອງຢາທີ່ມີເປົ້າ ໝາຍ lymphoma
ຢາທີ່ມີເປົ້າ ໝາຍ Lymphoma ສ່ວນໃຫຍ່ແມ່ນ rituximab (ການສັກຢາ rituximab), ວິທີການປິ່ນປົວແມ່ນປະມານ 10,000 ຫລື 20,000. ສະເພາະແມ່ນຂື້ນກັບສະຖານະການຂອງຄົນເຈັບເອງ. ຖ້າບໍ່ມີການຕໍ່ຕ້ານຢາເສບຕິດ, ທ່ານສາມາດສືບຕໍ່ກິນຢາໄດ້. ຖ້າມີຜົນຂ້າງຄຽງຫລືຕ້ານທານຢາ, ທ່ານ ຈຳ ເປັນຕ້ອງໂຈະຫລືໃຊ້ວິທີການປິ່ນປົວອື່ນໆ. ສະນັ້ນ, ລາຄາບໍ່ໄດ້ ກຳ ນົດ. ມັນຈະມີການປ່ຽນແປງ.
ເລືອດທີ່ສະອາດຢູ່ໃນຮ່າງກາຍໄດ້ຮັບການຄຸ້ມຄອງໂດຍລະບົບ hematopoietic, ແລະລະບົບ lymphatic ແມ່ນຜູ້ຈັດການ. ມີຜະລິດຕະພັນເອເລັກໂຕຣນິກຫຼາຍໃນປະຈຸບັນ, ແລະລັງສີແມ່ນມີຢູ່ທົ່ວທຸກບ່ອນ, ແລະມີການຕິດເຊື້ອໄວຣັດທີ່ປາກົດຢູ່ທຸກເວລາ. ເຫຼົ່ານີ້ແມ່ນສິ່ງຈູງໃຈຂອງ lymphoma Incentives, ທ່ານຕ້ອງໄດ້ເອົາໃຈໃສ່ຫຼາຍກວ່າທີ່ຈະຢູ່ຫ່າງຈາກ lymphomas ໃນຊີວິດ, ແລະການເລືອກຢາທີ່ຖືກເປົ້າ ໝາຍ ສຳ ລັບ lymphomas ແມ່ນບໍ່ມີເຫດຜົນ.
